PRODUCT DESCRIPTION
ARA-290, also known as cibinetide, is an 11-amino-acid peptide developed from the tissue-protective region of erythropoietin. It is designed to activate the innate repair receptor without stimulating red blood cell production in the same way as EPO. Research focuses on inflammation, tissue protection, and small nerve fibres.
Potential research benefits
- Small nerve fibre research: Early human studies have examined nerve-fibre density and neuropathic symptoms.
- Inflammation signalling: Investigating pathways involved in nerve injury and recovery.
- Tissue protection and repair: Studying the innate repair receptor's role in the response to tissue stress.
- Sensory and autonomic function: Exploring symptoms associated with small-fibre neuropathy.
Why researchers are interested
Small controlled studies in sarcoidosis and type 2 diabetes have reported encouraging findings involving neuropathic symptoms and selected nerve-fibre measurements. Larger, longer studies are needed to establish how consistently these findings translate into clinical benefit.